# FDA Inspection 961416 - Medtronic - February 01, 2016

Source: https://www.keypedia.com/records/fda_inspections/medtronic/92696a95-a0b5-4aff-9596-9bbac0cede9d
Source feed: FDA_Inspections

> FDA Inspection 961416 for Medtronic on February 01, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 961416
- Company Name: Medtronic
- Inspection Date: 2016-02-01
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 864805 - 2014-02-05](https://www.keypedia.com/records/fda_inspections/medtronic/d3c376f6-a570-4bb2-988d-579f94dd9447)
- [FDA Inspection 769018 - 2012-02-24](https://www.keypedia.com/records/fda_inspections/medtronic/4da8d2a9-1309-4028-8f3d-464c6f4922fd)
- [FDA Inspection 642881 - 2010-01-22](https://www.keypedia.com/records/fda_inspections/medtronic/9165a407-dcef-4399-8684-fe7843019ac5)

Company: https://www.keypedia.com/companies/medtronic/feea6959-5edd-4759-81af-3662e128e2aa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d